Loading clinical trials...
Loading clinical trials...
This is an Open Label, Uncontrolled Study to Evaluate the the Safety and Efficacy of SCT800 for Prophylaxis Treatment in Severe Previously Untreated Hemophilia Patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sinocelltech Ltd.
NCT03695978 · Haemophilia A
NCT06716814 · Haemophilia A (Moderate or Severe)
NCT06352216 · Haemophilia A, Synovitis, and more
NCT06285071 · Haemophilia A, Haemophilia B
NCT06831734 · Haemophilia A, Haemophilia B
Beijing children's hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions